Michael Kavanagh BSc, MBA (Advanced)
CEO, President and Managing Director
Michael joined Nanosonics as CEO and President effective October 2013. He was a Non-executive Director of the Board from July 2012 to October 2013. Michael has more than 25 years of international commercial experience in the healthcare market having held local, regional and global roles in medical device and pharmaceutical industries. Before joining Nanosonics, he was Senior Vice President of Global Marketing for the major medical device company Cochlear Ltd, a position he held for more than 10 years. He has no other current and former directorships in the last three years.
Chief Strategy Officer and Regional President Asia Pacific
David was a member of the Cochlear executive team for more than 14 years where he held a number of executive positions, including Senior Vice President of Strategy and Business Development, Global President for the Cochlear Bone Anchored Solutions Business based in Sweden and Chief Strategy Officer. Most recently, David was Chief Executive Officer and Managing Director for Monash IVF Group Limited. David joins Nanosonics as an Executive KMP.
McGregor Grant BEc, CA, GAICD
Chief Financial Officer and Company Secretary
McGregor joined Nanosonics in April 2011 and is responsible for the overall financial management of the Company, the IT function and, together with Michael Kavanagh, has joint responsibility for investor relations. He has more than 22 years’ business experience in a number of senior roles in the medical device and healthcare industries located in Australia and the United States and previously worked for Coopers & Lybrand (now PwC) in Australia and Europe.
Steven Farrugia, BE, PhD
Chief Technology Officer
Steven joined Nanosonics as Senior Vice President, Design and Development, in September 2016 and was appointed to the role of CTO in February 2018. He has over 20 years' experience leading the development of medical devices. Prior to Nanosonics, Steven held a range of senior executive roles with ResMed, including VP of Technology and VP of Product Development. He is an inventor of almost 300 granted and pending patents and is an Adjunct Professor of Engineering at The University of Sydney. In addition to Design and Development, Steven is responsible for the Regulatory Affairs function of the Company.
Chief Marketing Officer
Renee is a highly experienced international marketer having held senior executive roles including Executive Vice President and Worldwide Strategy Director for one of the world’s largest advertising agencies, Leo Burnett based in Chicago, and as Worldwide Chief Strategy Officer for the Publicis Healthcare Communications group based in Paris and Sydney. Most recently Renee was Head of Marketing for Abbott Nutrition based in Sydney.
Chief Operating Officer
Rod is an international operations executive with over 20 years of experience, having held critical roles in companies such as Cochlear and GM Holden. During his 13-year tenure at Cochlear, Rod held transformative roles such as Global Head of Manufacturing and Chair of the Operational Excellence Strategy Group. At GM Holden, Rod held senior management roles such as Launch/Operations Manager of Holden’s $400m HFV6 engine plant, and Global Customer Liaison Manager. Rod is also an award winning academic with continuing Adjunct Faculty appointments for over 12 years with MGSM, AGSM and the University of Sydney Business School. Rod joins Nanosonics as an Executive KMP.
Ken Shaw B.S. Finance
President – Americas
Ken joined Nanosonics in September 2017 as the head of our commercial operations in the United States, Canada, and Latin America. Ken has over 20 years of experience in healthcare related businesses, most recently as President for Amoena GMBH. Prior to that he held general management roles at BSN Medical, Medicom, Energizer and Pfizer.